Skip to the page

Data / Form D filings / Amplifi Vascular, Inc.

Amplifi Vascular, Inc.: Form D filings

Amplifi Vascular, Inc., a biotechnology company in Prairie Village, KS, filed 5 Form D notices with the SEC between 2023 and 2026. The latest, on June 30, 2026, reports $6 million sold of a $12 million offering to 59 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
3965 West 83rd Street, #300, Prairie Village, KS, 66208
Phone
(913) 730-0175
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2023
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1990753

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jun 30, 2026Amendment$12,000,000$5,960,278$6,039,72259Aug 21, 2024sec.gov
Mar 26, 2026Amendment$6,000,000$5,910,278$89,72259Aug 21, 2024sec.gov
Nov 27, 2024New notice$4,000,000$1,543,619$2,456,38123Aug 21, 2024sec.gov
Jun 25, 2024Amendment$8,000,000$808,000$7,192,0006Jul 28, 2023sec.gov
Aug 21, 2023New notice$7,000,000$558,000$6,442,0004Jul 28, 2023sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Sean MorrisExecutive Officer, Director
Nathaniel HagedornDirector
James SchultzDirector
Steve BraunDirector

Every Form D from the week of Jun 29, 2026 · All recent filings in Kansas · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Amplifi Vascular, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.